Device Manufacturers

Digital pathology comes with the promise of many advantages for the pathologists and fostering innovation in how pathology practices are transforming patient care. However, it will also contribute significantly to the healthcare data explosion...

When serum protein biomarker data were used independently, clinical sensitivity and specificity for detection of breast cancer were 74.7% and 77.0%, respectively. When tumor-associated autoantibody data were used independently,...

Honored and grateful beyond words to be among those chosen by my peers to receive this pioneering award for work in digital pathology. Countless folks over the past two decades have contributed to development of the technology, applications,...

Webinar Date – Thursday, August 25th 2016, 4:00 – 5.00pm Join Eileen Regan, Key Account Manager as she presents and demonstrates how Xplore & TMA can facilitate collaborative research within your organization by enabling easy access,...

If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a...

 CLINICAL TRACK OVERVIEW The clinical track at this year’s Pathology Visions will feature presentations and workshops by national and global leaders with experience and understanding of implementation of digital pathology solutions...